Articles dans des revues avec comité de lecture (167)
92.
Stoitchkov, K., Letellier, S., Garnier, J.-P., Bousquet, B., Tsankov, N., Morel, P., Ghanem, G. E., & Le Bricon, T. (2002). Melanoma progression and serum L-dopa/L-tyrosine ratio: a comparison with S100B. Melanoma research, 12(3), 255-262. doi:10.1097/00008390-200206000-0000994.
Ghanem, G. E., Loir, B., Morandini, R., Sales, F., Lienard, D., Eggermont, A., Lejeune, F., & EORTC Melanoma Group, (2001). On the release and half-life of S100B protein in the peripheral blood of melanoma patients. International journal of cancer, 94(4), 586-590. doi:10.1002/ijc.150495.
Jimenez-Cervantes Frigo, C., Olivares, C., González, P., Morandini, R., Ghanem, G. E., & García-Borrón, J. C. (2001). The Pro162 variant is a loss-of-function mutation of the human melanocortin 1 receptor gene. Journal of investigative dermatology, 117(1), 156-158. doi:10.1046/j.0022-202x.2001.01393.x97.
Kinnaert, E., Morandini, R., Simon, S., Hill, H. Z., Ghanem, G. E., & Van Houtte, P. (2000). The degree of pigmentation modulates the radiosensitivity of human melanoma cells. Radiation research, 154(5), 497-502.98.
Hedley, S. J., Murray, A., Sisley, K., Ghanem, G. E., Morandini, R., Gawkrodger, D. J., & Mac Neil, S. (2000). Alpha-melanocyte stimulating hormone can reduce T-cell interaction with melanoma cells in vitro. Melanoma research, 10(4), 323-330. doi:10.1097/00008390-200008000-0000399.
Haycock, J. W., Rowe, S. J., Cartledge, S., Wyatt, A., Ghanem, G. E., Morandini, R., Rennie, I. G., & MacNeil, S. (2000). Alpha-melanocyte-stimulating hormone reduces impact of proinflammatory cytokine and peroxide-generated oxidative stress on keratinocyte and melanoma cell lines. The Journal of biological chemistry, 275(21), 15629-15636. doi:10.1074/jbc.275.21.15629100.
Dupont, F., Avalosse, B., Karim, A., Mine, N., Bosseler, M., Maron, A., Van Den Broeke, A., Ghanem, G. E., Burny, A., & Zeicher, M. (2000). Tumor-selective gene transduction and cell killing with an oncotropic autonomous parvovirus-based vector. Gene therapy, 7(9), 790-796. doi:10.1038/sj.gt.3301161101.
Eves, P., Layton, C., Hedley, S. J., Dawson, R. A., Wagner, M., Morandini, R., Ghanem, G. E., & Mac Neil, S. (2000). Characterization of an in vitro model of human melanoma invasion based on reconstructed human skin. British journal of dermatology, 142(2), 210-222. doi:10.1046/j.1365-2133.2000.03287.x102.
Neil, S. M., Eves, P., Richardson, B., Molife, R., Lorigan, P., Wagner, M., Layton, C., Morandini, R., & Ghanem, G. E. (2000). Oestrogenic steroids and melanoma cell interaction with adjacent skin cells influence invasion of melanoma cells in vitro. Pigment cell research, 13 Suppl 8, 68-72.103.
Loir, B., Pérez Sánchez, C., Ghanem, G. E., Lozano, J. A., García-Borrón, J. C., & Jimenez-Cervantes Frigo, C. (1999). Expression of the MC1 receptor gene in normal and malignant human melanocytes. A semiquantitative RT-PCR study. Cellular and molecular biology, 45(7), 1083-1092.